Two Sigma Advisers »

Prelude Therapeutics shares owned by Two Sigma Advisers

Quarter-by-quarter ownership of Prelude Therapeutics (PRLD) shares owned by Two Sigma Advisers from 13F filings

Historical chart of Two Sigma Advisers investment in Prelude Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Prelude Therapeutics held by Two Sigma Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Prelude Therapeutics by Two Sigma Advisers

Quarter filed Position value Share count Share price at filing
2023-12-31 $264k 62k 4.27
2023-09-30 $96k 31k 3.09
2023-06-30 $211k 47k 4.50
2023-03-31 $288k 51k 5.70
2022-12-31 $455k 75k 6.04
2022-09-30 $724k 110k 6.61
2022-06-30 $1.2M 236k 5.22
2022-03-31 $873k 127k 6.90
2021-12-31 $1.0M 84k 12.46